Seres Therapeutics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Seres Therapeutics, Inc. (MCRB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $40.68 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2018-03-08
- Seres Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $40.68M, a 19.00% decline from fiscal 2016.
- Seres Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $50.22M, a 125.64% increase from fiscal 2015.
- Seres Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $22.25M, a 257.34% increase from fiscal 2014.
- Seres Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $6.23M, a 131.09% increase from fiscal 2013.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2017-12-31 | $40.68M 10-K · filed 2018-03-08 |
| 2016-12-31 | $50.22M 10-K · filed 2018-03-08 |
| 2015-12-31 | $22.25M 10-K · filed 2018-03-08 |
| 2014-12-31 | $6.23M 10-K · filed 2017-03-16 |
| 2013-12-31 | $2.69M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |